{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:21:22Z","timestamp":1787505682127,"version":"build-2736575974"},"reference-count":57,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CDC\/HHS"},{"name":"U.S. Government"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Misuse"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/10826084.2025.2540947","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T10:11:43Z","timestamp":1755166303000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the Impact of an Influencer-Led Program on Community Support for Harm Reduction in West Virginia: A Preliminary Evaluation"],"prefix":"10.1080","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5635-5896","authenticated-orcid":false,"given":"Megan","family":"Leibensperger","sequence":"first","affiliation":[{"name":"The Public Good Projects","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-4920","authenticated-orcid":false,"given":"Melissa","family":"Dunn Silesky","sequence":"additional","affiliation":[{"name":"The Public Good Projects","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Gudmundsen","sequence":"additional","affiliation":[{"name":"CDC Foundation","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-5123","authenticated-orcid":false,"given":"Erika","family":"Bonnevie","sequence":"additional","affiliation":[{"name":"The Public Good Projects","place":["Alexandria, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"Cabell-Huntington Health Department. (n.d). Harm reduction program. Cabell-Huntington Health Department. https:\/\/cabellhealth.org\/clinical-services\/harm-reduction\/"},{"key":"e_1_3_7_3_1","unstructured":"Ad Council. (n.d.). Reduce the risk: Carry Naloxone. Real Deal on Fentanyl. https:\/\/realdealonfentanyl.com\/reduce-the-risk"},{"key":"e_1_3_7_4_1","unstructured":"Ahmad F. Cisewski J. Rossen L. & Sutton P. (2023 June 6). Provisional drug overdose death counts. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0305-7"},{"key":"e_1_3_7_6_1","volume-title":"SSWR","author":"Anasti T.","year":"2022","unstructured":"Anasti, T. (2022, January 15). Abstract: Is Nimbyism the Problem?: Efforts to Introduce Rural Communities to Syringe Exchange Programs (Society for Social Work and Research 26th Annual Conference\u2014Social Work Science for Racial, Social, and Political Justice) [Paper presentation]. SSWR. https:\/\/sswr.confex.com\/sswr\/2022\/webprogram\/Paper46275.html"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0022243719879711"},{"key":"e_1_3_7_8_1","unstructured":"Benham B. & Scullin R. (2018 June 5). Public Support For Needle Exchange Programs Safe Injection Sites Remain Low in U.S. | Johns Hopkins | Bloomberg School of Public Health. John Hopkins Bloomberg School of Public Health. https:\/\/publichealth.jhu.edu\/2018\/public-support-for-needle-exchange-programs-safe-injection-sites-remains-low-in-US"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/15248399221083844"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3943691"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/00178969231197623"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/00178969221077409"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240828"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/her\/cyab018"},{"key":"e_1_3_7_15_1","unstructured":"Centers for Disease Control and Prevention & National Center for Health Statistics. (2022 March 1). Drug Overdose Mortality by State. National Center for Health Statistics. https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm"},{"key":"e_1_3_7_16_1","unstructured":"Centers for Disease Control and Prevention. (2022). CDC\u2019s Campaigns to Stop Overdose: An Executive Summary. https:\/\/www.cdc.gov\/stopoverdose\/pdf\/stop-overdose-executive-summary-508.pdf"},{"key":"e_1_3_7_17_1","unstructured":"Centers for Disease Control and Prevention. (2023 April 21). Lifesaving Naloxone. Stop Overdose. https:\/\/www.cdc.gov\/stopoverdose\/naloxone\/index.html"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0397-9"},{"key":"e_1_3_7_19_1","unstructured":"Coyne C. (2022 September 7). CDC: Fatal overdoses drop slightly in WV from March 2021\u201322. West Virginia Office of Drug Control Policy. https:\/\/dhhr.wv.gov\/office-of-drug-control-policy\/newsannouncements\/Pages\/Test-News-Item-2.aspx"},{"key":"e_1_3_7_20_1","unstructured":"DeGoede B. (2023 August 25). Council Post: Micro-Influencer Power: Building Brand Trust And Driving Conversions. Forbes. https:\/\/www.forbes.com\/councils\/forbesagencycouncil\/2023\/08\/25\/the-power-of-micro-influencers-building-brand-trust-and-driving-conversions\/"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1521\/aeap.17.1.68.58688"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-022-01170-9"},{"key":"e_1_3_7_23_1","unstructured":"Geyser W. (2017 March 14). What is an Influencer? \u2013 Social Media Influencers Defined [Updated 2023]. Influencer Marketing Hub. https:\/\/influencermarketinghub.com\/what-is-an-influencer\/"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(03)00075-6"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00518-z"},{"key":"e_1_3_7_26_1","unstructured":"IPSOS. (2023). Ipsos Answers to ESOMAR 37 Questions for Users and Buyers of Online Samples"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-015-0022-5"},{"key":"e_1_3_7_28_1","unstructured":"Lieberman A. & Davis C. (2020 December 2). Harm Reduction Laws in the United States. Network for Public Health Law. https:\/\/www.networkforphl.org\/resources\/harm-reduction-laws-in-the-united-states\/"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.02.026"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/1524839906292821"},{"key":"e_1_3_7_31_1","unstructured":"NASEN. (n.d). NASEN | North America Syringe Exchange Network: NASEN Directory. https:\/\/nasen.org"},{"key":"e_1_3_7_32_1","unstructured":"National Center for HIV Viral Hepatitis STD and TB Prevention. (2019 July 24). Syringe Services Programs (SSPs) Fact Sheet | CDC. Syringe Services Programs (SSPs). https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-factsheet.html"},{"key":"e_1_3_7_33_1","unstructured":"National Association of Counties. (2023 January 23). A NACo Opioid Solutions Strategy Brief: Syringe Services Programs. NACo. https:\/\/www.naco.org\/resource\/syringe-services-programs"},{"key":"e_1_3_7_34_1","unstructured":"National Center for Injury Prevention and Control & Centers for Disease Control and Prevention. (2022 June 9). Evidence-Based Strategies for Preventing Opioid Overdose: What\u2019s Working in the United States. Drug Overdose. https:\/\/www.cdc.gov\/drugoverdose\/featured-topics\/evidence-based-strategies.html"},{"key":"e_1_3_7_35_1","unstructured":"National Harm Reduction Coalition. (2020). Harm Reduction Principles. National Harm Reduction Coalition. https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/"},{"key":"e_1_3_7_36_1","unstructured":"National Institute on Drug Abuse. (2021 June 7). Syringe Services Programs. National Institute on Drug Abuse. https:\/\/nida.nih.gov\/research-topics\/syringe-services-programs"},{"key":"e_1_3_7_37_1","unstructured":"National Institute on Drug Abuse. (2023 June 30). Drug Overdose Death Rates. National Institute on Drug Abuse. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_3_7_38_1","unstructured":"Newman T. & Malone G. (2022 June 15). As Overdose Crisis Continues Pennsylvania Extends Innovative Campaign to Promote Naloxone Use and Combat Stigma. Vital Strategies. https:\/\/www.vitalstrategies.org\/as-overdose-crisis-continues-pennsylvania-extends-innovative-campaign-to-promote-naloxone-use-and-combat-stigma\/"},{"key":"e_1_3_7_39_1","unstructured":"Newman T. & Malone G. (2023). Vital strategies\u201dSupport Harm Reduction\u201d Campaign Wins The Webby\u2019s Anthem Award. Vital Strategies. https:\/\/www.vitalstrategies.org\/vital-strategies-support-harm-reduction-campaign-wins-the-webbys-anthem-award\/"},{"key":"e_1_3_7_40_1","unstructured":"Office of Management and Budget. (2024 March 29). Revisions to OMB\u2019s Statistical Policy Directive No. 15: Standards for Maintaining Collecting and Presenting Federal Data on Race and Ethnicity. Federal Register. https:\/\/www.federalregister.gov\/documents\/2024\/03\/29\/2024-06469\/revisions-to-ombs-statistical-policy-directive-no-15-standards-for-maintaining-collecting-and"},{"key":"e_1_3_7_41_1","article-title":"Defending syringe services programs","author":"Oliva J. D.","year":"2021","unstructured":"Oliva, J. D., El-Sabawi, T., Canzater, S. L., & Weizman, S. R. (2021). Defending syringe services programs. Health Affairs Forefront, https:\/\/www.healthaffairs.org\/do\/10.1377\/forefront.20210817.592015\/full\/","journal-title":"Health Affairs Forefront,"},{"key":"e_1_3_7_42_1","unstructured":"Prevention First. (n.d). Naloxone Now: Stand Against Opioid Overdose. https:\/\/www.prevention.org\/Resources\/14571282-ef6e-4628-b793-5e4188e246c6\/NaloxoneNow_WhatIsNaloxone_mediakit_full-v1-4.pdf"},{"key":"e_1_3_7_43_1","unstructured":"Safe Project. (2023). State Naloxone Access Rules and Resources. SAFE Project. https:\/\/www.safeproject.us\/naloxone\/awareness-project\/state-rules\/"},{"key":"e_1_3_7_44_1","unstructured":"SB 334 Text S.B. 334 WEST VIRGINIA LEGISLATURE 2021 Regular Session. (2021). https:\/\/www.wvlegislature.gov\/Bill_Status\/bills_text.cfm?billdoc=SB334+SUB1+ENR.htm&i=334&sesstype=RS&yr=2021"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1524839917742850"},{"key":"e_1_3_7_46_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2023a January 4). SAMHSA Announces National Survey on Drug Use and Health (NSDUH) Results Detailing Mental Illness and Substance Use Levels in 2021 [Text]. HHS.Gov. https:\/\/www.hhs.gov\/about\/news\/2023\/01\/04\/samhsa-announces-national-survey-drug-use-health-results-detailing-mental-illness-substance-use-levels-2021.html"},{"key":"e_1_3_7_47_1","unstructured":"Substance Abuse and Mental Health Services Administration. (2023b February 22). Harm Reduction. Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/substance-use\/harm-reduction"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.10.018"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2005.065961"},{"key":"e_1_3_7_50_1","unstructured":"The Homeless Hub. (2021). Harm reduction. About homelessness. https:\/\/www.homelesshub.ca\/about-homelessness\/substance-use-addiction\/harm-reduction"},{"key":"e_1_3_7_51_1","unstructured":"U.S. Department of Health and Human Services. (2021 September 14). Overdose Prevention Strategy [Text]. Overdose Prevention Strategy. https:\/\/www.hhs.gov\/overdose-prevention\/overdose-prevention-strategy"},{"key":"e_1_3_7_52_1","unstructured":"U.S. Food and Drug Administration. (2023 March 29). FDA Approves First Over-the-Counter Naloxone Nasal Spray. FDA. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-over-counter-naloxone-nasal-spray"},{"key":"e_1_3_7_53_1","unstructured":"United Nations Office on Drugs and Crime. United Nations. (2024 June 26). World Drug Report 2024. Office on Drugs and Crime www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcs.12647"},{"key":"e_1_3_7_55_1","unstructured":"West Virginia Bureau for Public Health (BPH). (2004 March 11). West Virginia HIV\/AIDS & STD Program. West Virginia HIV\/AIDS & STD Program. https:\/\/www.wvdhhr.org\/bph\/oehp\/sdc\/aids.htm"},{"key":"e_1_3_7_56_1","unstructured":"West Virginia Office of Epidemiology and Prevention Services. (n.d). About harm reduction. https:\/\/oeps.wv.gov\/harm_reduction\/documents\/interactive\/hrp.aspx#box"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251860"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2021.1979837"}],"container-title":["Substance Use &amp; Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2025.2540947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T19:33:15Z","timestamp":1764617595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2025.2540947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/10826084.2025.2540947"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2025.2540947","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}